Correlation Between Equillium and Atea PharmaceuticalsI

Can any of the company-specific risk be diversified away by investing in both Equillium and Atea PharmaceuticalsI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and Atea PharmaceuticalsI into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Equillium and Atea PharmaceuticalsInc, you can compare the effects of market volatilities on Equillium and Atea PharmaceuticalsI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of Atea PharmaceuticalsI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and Atea PharmaceuticalsI.

Diversification Opportunities for Equillium and Atea PharmaceuticalsI

0.7

Correlation Coefficient

Equillium  Atea PharmaceuticalsI

Poor diversification

The 3 months correlation between Equillium and Atea is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and Atea PharmaceuticalsInc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atea PharmaceuticalsInc and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with Atea PharmaceuticalsI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atea PharmaceuticalsInc has no effect on the direction of Equillium i.e., Equillium and Atea PharmaceuticalsI go up and down completely randomly.

Pair Corralation between Equillium and Atea PharmaceuticalsI

Allowing for the 90-day total investment horizon Equillium is expected to under-perform the Atea PharmaceuticalsI. In addition to that, Equillium is 1.86 times more volatile than Atea PharmaceuticalsInc. It trades about -0.09 of its total potential returns per unit of risk. Atea PharmaceuticalsInc is currently generating about -0.13 per unit of volatility. If you would invest  396.00  in Atea PharmaceuticalsInc on March 4, 2024 and sell it today you would lose (29.00) from holding Atea PharmaceuticalsInc or give up 7.32% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Equillium  vs.  Atea PharmaceuticalsInc

Equillium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in July 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Atea PharmaceuticalsInc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Atea PharmaceuticalsInc has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's forward indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Pair Trading with Equillium and Atea PharmaceuticalsI

The main advantage of trading using opposite Equillium and Atea PharmaceuticalsI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, Atea PharmaceuticalsI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea PharmaceuticalsI will offset losses from the drop in Atea PharmaceuticalsI's long position.

The idea behind Equillium and Atea PharmaceuticalsInc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..